Journal article icon

Journal article

Ever closer to a prophylactic vaccine for HCV.

Abstract:

INTRODUCTION: With 3 - 4 million new infections occurring annually, hepatitis C virus (HCV) is a major global health problem. There is increasing evidence to suggest that HCV will be highly amenable to a vaccine approach, and despite advances in treatment, a vaccine remains the most cost-effective and realistic means to significantly reduce the worldwide mortality and morbidity associated with persistent HCV infection. AREAS COVERED: In this review we discuss immune responses to HCV during na...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
Journal:
Expert opinion on biological therapy More from this journal
Volume:
13
Issue:
8
Pages:
1109-1124
Publication date:
2013-08-01
DOI:
EISSN:
1744-7682
ISSN:
1471-2598
Language:
English
Keywords:
Pubs id:
pubs:401803
UUID:
uuid:8ecef0f3-91b2-4988-8504-a7d46383583b
Local pid:
pubs:401803
Source identifiers:
401803
Deposit date:
2013-11-16

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP